Publicacións

Publicacións de María De La Fuente Freire

83 resultados

2026

  1. Evaluation of Self-Illuminating Nanoconjugates Against Pancreatic Ductal Adenocarcinoma

    International Journal of Nanomedicine, Vol. 21

  2. Nanoencapsulated senotherapeutic compounds targeting connexin-43 for enhanced wound healing

    iScience, Vol. 29, Núm. 2

  3. Protamine nanocapsules as gene delivery carriers for the treatment of intraocular tumors

    Drug Delivery and Translational Research, Vol. 16, Núm. 6, pp. 1754-1772

2025

  1. Biocompatible self-illuminating sphingomyelin nanosystems for photodynamic-based cancer therapy

    Journal of Controlled Release, Vol. 385

  2. Development and Characterization of Magnetic Nanoemulsion-Based Senolytic Peptides for Osteoarthritis Treatment

    International Journal of Molecular Sciences, Vol. 26, Núm. 3

  3. Mechanistic Insights into Sphingomyelin Nanoemulsions as Drug Delivery Systems for Non-Small Cell Lung Cancer Therapy

    Pharmaceutics, Vol. 17, Núm. 4

  4. Protamine-Based Nanotherapeutics for Gene Delivery to Glioblastoma Cells

    Molecular Pharmaceutics, Vol. 22, Núm. 5, pp. 2466-2481

  5. Targeted delivery of therapeutics to metastatic lung cancer cells using aptamer-conjugated nanoemulsions

    Journal of Controlled Release, Vol. 385

2024

  1. Anakinra-Loaded Sphingomyelin Nanosystems Modulate In Vitro IL-1-Dependent Pro-Tumor Inflammation in Pancreatic Cancer

    International Journal of Molecular Sciences, Vol. 25, Núm. 15

  2. Aptamer functionalization effect on the interaction of sphingomyelin nanoemulsions with plasma proteins. A thermodynamic approach

    Journal of Molecular Liquids, Vol. 397

  3. Multicellular tumor spheroid model to study the multifaceted role of tumor-associated macrophages in PDAC

    Drug Delivery and Translational Research, Vol. 14, Núm. 8, pp. 2085-2099

  4. Reprogramming tumor-associated macrophages with lipid nanosystems reduces PDAC tumor burden and liver metastasis

    Journal of Nanobiotechnology , Vol. 22, Núm. 1

  5. Versatile and Efficient Protein Association Through Chemically Modified Sphingomyelin Nanosystems (SNs) for Enhanced Delivery

    ChemBioChem, Vol. 25, Núm. 23

2023

  1. Chemical conjugation of aptamer-sphingomyelin nanosystems and their potential as inhibitors of tumour cell proliferation in breast cancer cells

    Nanoscale, Vol. 15, Núm. 47, pp. 19110-19127

  2. Development of a new plasma rich in growth factors membrane with improved optical properties

    Annals of Anatomy, Vol. 248

  3. Effectiveness of a novel gene nanotherapy based on putrescine for cancer treatment

    Biomaterials Science, Vol. 11, Núm. 12, pp. 4210-4225

  4. Efficacy of Platelet-Rich Plasma in Women with a History of Embryo Transfer Failure: A Systematic Review and Meta-Analysis with Trial Sequential Analysis

    Bioengineering, Vol. 10, Núm. 3

  5. Erratum: Effectiveness of a novel gene nanotherapy based on putrescine for cancer treatment (Biomaterials Science (2023) DOI: 10.1039/d2bm01456d

    Biomaterials Science

  6. Exosome-like systems: Nanotechnology to overcome challenges for targeted cancer therapies

    Cancer Letters, Vol. 561

  7. PEGylation Effects on the Interaction of Sphingomyelin Nanoemulsions with Serum Albumin: A Thermodynamic Investigation

    Macromolecular Materials and Engineering, Vol. 308, Núm. 6